Programmable intrathecal pumps for the management of chronic pain: Recommendations for improved efficiency

Journal of Pain Research

Volumn 7, Issue , 2014, Pages 571-577

  Wilkes, Denise ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Chronic pain; Implantable drug delivery; Intrathecal morphine; Programmable drug delivery

Indexed keywords

CHLORHEXIDINE; MORPHINE; OPIATE; PSEUDOMONIC ACID;

ANALGESIA; CATHETER COMPLICATION; CATHETER DISCONNECTION; CATHETER DISLOCATION; CATHETER LEAKAGE; CATHETER OCCLUSION; CHRONIC PAIN; CONTINUOUS INFUSION; DRUG DELIVERY SYSTEM; DRUG IMPLANT; DRUG MICRODOSE; GRANULOMA; HUMAN; IMPLANTABLE PUMP; INFECTION; INFUSION PUMP; INFUSION SYSTEM; INTRATHECAL CATHETER; INTRATHECAL DRUG ADMINISTRATION; INTRATHECAL PUMP; MEDICAL DEVICE COMPLICATION; PAIN ASSESSMENT; PEROPERATIVE CARE; POSTOPERATIVE PERIOD; REVIEW; SURGICAL DRAPE; SURGICAL INFECTION; SURGICAL TECHNIQUE; VISUAL ANALOG SCALE;

EID: 84908085478     PISSN: 11787090     EISSN: 11787090     Source Type: Journal    
DOI: 10.2147/JPR.S46929     Document Type: Review

References (44)

1. Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol. 2001;19(9):2542-2554.
2. Manchikanti L, Abdi S, Atluri S, et al. An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendations. Pain Physician. 2013;16(Suppl 2):S49-S283.
3. Ghafoor VL, Epshteyn M, Carlson GH, Terhaar DM, Charry O, Phelps PK. Intrathecal drug therapy for long-term pain management. Am J Health Syst Pharm. 2007;64(23):2447-2461.
4. Deer T, Winkelmuller W, Erdine S, Bedder M, Burchiel K. Intrathecal therapy for cancer and nonmalignant pain: patient selection and patient management. Neuromodulation. 1999;2(2):55-66.
5. Chauvin M, Samii K, Schermann JM, Sandouk P, Bourdon R, Viars P. Plasma pharmacokinetics of morphine after im, extradural and intrathecal administration. Br J Anaesth. 1982;54(8):843-847.
6. McCracken LM, Iverson GL. Predicting complaints of impaired cognitive functioning in patients with chronic pain. J Pain Symptom Manage. 2001;21(5):392-396.
7. Sjogren P, Thomsen AB, Olsen AK. Impaired neuropsychological performance in chronic nonmalignant pain patients receiving long-term oral opioid therapy. J Pain Symptom Manage. 2000;19(2):100-108.
8. Cousins MJ, Mather LE. Intrathecal and epidural administration of opioids. Anesthesiology. 1984;61(3):276-310.
9. Dickenson AH. Spinal cord pharmacology of pain. Br J Anaesth. 1995;75(2):193-200.
10. Hayek SM, Deer TR, Pope JE, Panchal SJ, Patel VB. Intrathecal therapy for cancer and non-cancer pain. Pain Physician. 2011;14(3): 219-248.
11. Falco FJ, Patel VB, Hayek SM, et al. Intrathecal infusion systems for long-term management of chronic non-cancer pain: an update of assessment of evidence. Pain Physician. 2013;16(Suppl 2):SE185-SE216.
12. Maeyaert J, Buchser E, Van Buyten JP, Rainov NG, Becker R. Patient-controlled analgesia in intrathecal therapy for chronic pain: safety and effective operation of the model 8831 personal therapy manager with a pre-implanted synchromed infusion system. Neuromodulation. 2003;6(3):133-141.
13. Ilias W, le Polain B, Buchser E, Demartini L. Patient-controlled analgesia in chronic pain patients: experience with a new device designed to be used with implanted programmable pumps. Pain Pract. 2008;8(3): 164-170.
14. Hayek SM, Hanes MC. Intrathecal therapy for chronic pain: current trends and future needs. Curr Pain Headache Rep. 2014;18(1):388.
15. Deer TR, Prager J, Levy R, et al. Polyanalgesic Consensus Conference - 2012: recommendations on trialing for intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation. 2012;15(5):420-435; discussion 435.
16. Anderson VC, Burchiel KJ, Cooke B. A prospective, randomized trial of intrathecal injection vs epidural infusion in the selection of patients for continuous intrathecal opioid therapy. Neuromodulation. 2003;6(3): 142-152.
17. The British Pain Society. Intrathecal drug delivery for the management of pain and spasticity in adults; recommendations for best clinical practice. London: The British Pain Society; 2008. Available from: http://www.britishpainsociety.org/book_ittd_main.pdf. Accessed September 23, 2014.
18. Deer TR. Polyanalgesic Consensus Conference 2012. Neuromodulation. 2012;15(5):418-419.
19. Kumar K, Kelly M, Pirlot T. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy. Surg Neurol. 2001;55(2):79-86. discussion 86-78.
20. Rauck RL, Cherry D, Boyer MF, Kosek P, Dunn J, Alo K. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain. J Pain. 2003;4(8):441-447.
21. Grider JS, Harned ME, Etscheidt MA. Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain. Pain Physician. 2011;14(4):343-351.
22. Kim D, Saidov A, Mandhare V, Shuster A. Role of pretrial systemic opioid requirements, intrathecal trial dose, and non-psychological factors as predictors of outcome for intrathecal pump therapy: one clinician's experience with lumbar postlaminectomy pain. Neuromodulation. 2011;14((2):165-175; discussion 175.
23. Deer TR, Levy R, Prager J, et al. Polyanalgesic Consensus Conference - 2012: recommendations to reduce morbidity and mortality in intrathecal drug delivery in the treatment of chronic pain. Neuromodulation. 2012;15(5):467-482; discussion 482.
24. Deer TR, Prager J, Levy R, et al. Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation. 2012;15(5):436-464; discussion 464-466.
25. Deer TR, Prager J, Levy R, et al. Polyanalgesic Consensus Conference - 2012: consensus on diagnosis, detection, and treatment of catheter-tip granulomas (inflammatory masses). Neuromodulation. 2012;15(5):483-495; discussion 496.
26. Fluckiger B, Knecht H, Grossmann S, Felleiter P. Device-related complications of long-term intrathecal drug therapy via implanted pumps. Spinal Cord. 2008;46(9):639-643.
27. Rosenow JM. Surgical techniques for intrathecal medication delivery system implantation. In: Krames ES, Peckham PH, Rezai AR, editors. Neuromodulation. London: Elsevier; 2009:1027-1032.
28. Buvanendran A, Jaycox M, Deer TR. Techniques of implant placement for intrathecal pumps. In: Deer TR, editor. Intrathecal Drug Delivery for Pain and Spasticity. Vol 2. Philadelphia: Saunders; 2012:78-83.
29. Follett KA, Naumann CP. A prospective study of catheter-related complications of intrathecal drug delivery systems. J Pain Symptom Manage. 2000;19(3):209-215.
30. Engle MP, Vinh BP, Harun N, Koyyalagunta D. Infectious complications related to intrathecal drug delivery system and spinal cord stimulator system implantations at a comprehensive cancer pain center. Pain Physician. 2013;16(3):251-257.
31. Alexander JW, Solomkin JS, Edwards MJ. Updated recommendations for control of surgical site infections. Ann Surg. 2011;253(6): 1082-1093.
32. 1c is a risk factor for surgical site infection after posterior thoracic and lumbar spinal instrumentation surgery. J Orthop Sci. 2014;19(2):223-228.
33. Bertrand X, Slekovec C, Talon D. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010;362(1): 9-17.
34. Sorensen LT, Karlsmark T, Gottrup F. Abstinence from smoking reduces incisional wound infection: a randomized controlled trial. Ann Surg. 2003;238(1):1-5.
35. Darouiche RO, Wall MJ Jr, Itani KM, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med. 2010;362(1):18-26.
36. Alexander JW, Aerni S, Plettner JP. Development of a safe and effective one-minute preoperative skin preparation. Arch Surg. 1985;120(12): 1357-1361.
37. Rosenberg AD, Wambold D, Kraemer L, et al. Ensuring appropriate timing of antimicrobial prophylaxis. J Bone Joint Surg Am. 2008;90(2): 226-232.
38. Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med. 1996;334(19):1209-1215.
39. Biswas D, Bible JE, Whang PG, Simpson AK, Grauer JN. Sterility of C-arm fluoroscopy during spinal surgery. Spine (Phila PA 1976). 2008;33(17):1913-1917.
40. Peters PG, Laughlin RT, Markert RJ, Nelles DB, Randall KL, Prayson MJ. Timing of C-arm drape contamination. Surg Infect (Larchmt). 2012;13(2):110-113.
41. Bible JE, O'Neill KR, Crosby CG, Schoenecker JG, McGirt MJ, Devin CJ. Implant contamination during spine surgery. Spine J. 2013;13(6): 637-640.
42. Hutchinson JJ, Lawrence JC. Wound infection under occlusive dressings. J Hosp Infect. 1991;17(2):83-94.
43. Hutchinson JJ, McGuckin M. Occlusive dressings: a microbiologic and clinical review. Am J Infect Control. 1990;18(4):257-268.
44. Hamza M, Doleys D, Wells M, et al. Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain. Pain Med. 2012;13(10):1304-1313.